Prospective Study
Copyright ©The Author(s) 2018.
World J Gastroenterol. Jun 7, 2018; 24(21): 2300-2310
Published online Jun 7, 2018. doi: 10.3748/wjg.v24.i21.2300
Table 2 Clinical characteristics of hepatitis B virus-related acute-on-chronic liver failure and hepatitis B virus-related decompensated cirrhosis patients after enrollment
CharacteristicsHBV-DC
HBV-ACLF
P valueaP valueb
DC-non-AKI (n = 104)DC-AKI (n = 28)ACLF-non-AKI (n = 209)ACLF-AKI (n = 71)
Hospitalization (d)113 (8-20)12.5 (9-18.3)26 (17-43)16 (10.5-33)0.144< 0.001
Complications
Ascites (%)280 (76.9)28 (100)141 (67.5)67 (94.4)0.570< 0.001
HE (%)28 (7.7)3 (10.7)41 (19.6)31 (43.7)< 0.001< 0.001
GI bleeding (%)211 (10.6)5 (17.9)5 (2.4)6 (8.5)0.1510.002
SBP (%)222 (21.2)19 (67.9)68 (32.5)47 (66.2)0.872< 0.001
Pulmonary infection (%)220 (19.2)8 (28.6)43 (20.6)23 (32.4)0.9440.134
Serum creatinine (mg/dL)1
Baseline0.78 (0.68-0.87)0.97 (0.81-1.23)0.68 (0.6-0.81)0.94 (0.74-1.26)0.665< 0.001
Peak0.84 (0.74-0.96)1.69 (1.44-2.07)0.83 (0.7-0.94)1.99 (1.63-2.57)0.028< 0.001
Final0.76 (0.66-0.87)1.05 (0.77-1.48)0.74 (0.64-0.85)1.48 (0.98-2.32)0.014< 0.001
Treated with terlipressin (%)2-19 (67.9)-43 (60.6)0.499-
Treatment time1-5 (3-9)-6 (3-9)0.023-
30-d mortality27 (6.7)9 (32.1)38 (18.2)42 (59.2)0.015< 0.001
90-d mortality210 (9.6)14 (50)69 (33)51 (71.8)0.039< 0.001